What is the current Price Target for the Anixa Biosciences, Inc. stock?

The average Anixa Biosciences, Inc. target price is $9.00. This is 246.15% higher than the current stock price. The highest price target is 284.62%, the lowest is 169.23%. 3 Analysts have issued a price target Anixa Biosciences, Inc. 2026 .

How high will the Anixa Biosciences, Inc. stock rise?

No reliable answer can be given as to how high the Anixa Biosciences, Inc. stock will rise. The performance of stocks, including the Anixa Biosciences, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Anixa Biosciences, Inc. stock today?

The performance of Anixa Biosciences, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Anixa Biosciences, Inc. stock fall?

The decline in Anixa Biosciences, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Anixa Biosciences, Inc. Forecast, price target & analysts

$2.53

2.69% today

Nasdaq, Apr 04, 07:17 pm CET

ISIN

US03528H1095

Symbol

ANIX

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Technology

Industry

Computer Hardware

Overview Dividends Analysts Charts News Strategies

Anixa Biosciences, Inc. Target price 2025 - Analyst rating & recommendation

Anixa Biosciences, Inc. Classifications & Recommendation:

Buy

100%

Anixa Biosciences, Inc. Price Target

Target Price	$9.00
Price	$2.60
Potential	246.15% register free of charge
Number of Estimates	3

	3 Analysts have issued a price target Anixa Biosciences, Inc. 2026 . The average Anixa Biosciences, Inc. target price is $9.00. This is 246.15% register free of charge higher than the current stock price. The highest price target is $10.00 284.62% register free of charge , the lowest is $7.00 169.23% register free of charge .
	A rating was issued by 3 analysts: 3 Analysts recommend Anixa Biosciences, Inc. to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Anixa Biosciences, Inc. stock has an average upside potential 2026 of 246.15% register free of charge . Most analysts recommend the Anixa Biosciences, Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Oct '24	2025 Estimates
Earnings Per Share $	-0.39	-0.34
	21.88%	12.82%
P/E		negative

2 Analysts have issued a Anixa Biosciences, Inc. forecast for earnings per share. The average Anixa Biosciences, Inc. EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-0.39	21.88%
2025	$-0.34 12.82% Unlock
2026	$-0.34 0.00% Unlock
2027	$-0.34 0.00% Unlock
2028	$-0.36 5.88% Unlock
2029	$-0.23 36.11% Unlock

Current	-6.68	26.11%
2025	-7.65 14.52% Unlock
2026	-7.76 1.44% Unlock
2027	-7.65 1.42% Unlock
2028	-7.22 5.62% Unlock
2029	-11.30 56.51% Unlock

Anixa Biosciences, Inc....

Current Anixa Biosciences, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
D. Boral Capital	Locked ➜ Locked	Locked	Mar 26 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Mar 25 2025
Maxim Group	Locked ➜ Locked	Locked	Mar 21 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Feb 18 2025
D. Boral Capital	Locked ➜ Locked	Locked	Jan 22 2025
D. Boral Capital	Locked ➜ Locked	Locked	Jan 14 2025
D. Boral Capital	Locked ➜ Locked	Locked	Nov 19 2024

Analyst Rating	Date
Locked D. Boral Capital: Locked ➜ Locked	Mar 26 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Mar 25 2025
Locked Maxim Group: Locked ➜ Locked	Mar 21 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Feb 18 2025
Locked D. Boral Capital: Locked ➜ Locked	Jan 22 2025
Locked D. Boral Capital: Locked ➜ Locked	Jan 14 2025
Locked D. Boral Capital: Locked ➜ Locked	Nov 19 2024

Discover more stocks with a high price target

Novo Nordisk 83.92%

Coinbase Global, Inc. 83.53%

BioNTech SE - ADR 50.09%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now